Nautilus Biotechnology, Inc. (NAUT) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Core Perspective - Nautilus aims to position itself within the proteomics ecosystem by addressing key differentiators and challenges in the field of proteomics, particularly in real-time measurement of proteins compared to the established methods of genomic measurement [1] Group 1: Proteomics Context - The company highlights the advancements made in genomic measurement over the past decades, noting that it is now possible to accurately and quickly measure 99.9% of an individual's DNA from a small blood sample [1] - However, the limitation of genomic data is that it remains static throughout a person's life, failing to reflect the dynamic state of biological processes [1] Group 2: Company Differentiation - Nautilus is focused on solving the challenges associated with real-time protein measurement, which is crucial for understanding the current biological state of individuals [1] - The company seeks to differentiate itself by providing solutions that go beyond static genomic data, aiming to capture the complexities of proteomics [1]